2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
Order this Report
A Closer Look at the Science Tools Sector: Alastair Mackay, GARP Research & Securities Co.
Medical Diagnostics & Life Sciences: Zarak Khurshid, Caris & Company, Inc.
CEO Interviews (average 2,500 words): Top management from Arrowhead Research Corporation, Cleveland BioLabs Inc., IR BioSciences Holdings Inc., and Power3 Medical Products Inc. examine the outlook for their firm and sector.
Topics covered: Medical Device Research Services - Pharmaceutical Research Services - Diagnostics - Life Science Research Supplies - Biology R & D - Lab Services Business Model - International Economic Exposure - Effect of Recession on Sector Stocks - Top Stock Winners and Losers in Medical Research Services - Top Stock Winners and Losers in Medical Diagnostics
ORDER THIS REPORT NOW! CLICK HERE
Companies covered: Arrowhead Research (ARWR); Cleveland BioLabs (CBLI); IR BioSciences Holdings (IRBS); Power3 Medical Products (PWRM); Illumina (ILMN); Luminex (LMNX); Waters (WAT); Life Technologies (LIFE); QIAGEN (QGEN); Sangamo BioSciences (SGMO); Beckman Coulter (BEC); Invitrogen (IVGN); Amgen (AMGN); Bristol-Myers (BMY); Eli Lilly & Co. (LLY); Myriad Genetics (MYGN); Genomic Health (GHDX); Targeted Genetics (TGEN); Dow Chemical (DOW); Sigma-Aldrich (SIAL); MDS (MDZ); Danaher (DHR); Cepheid (CPHD); Inverness Medical Innovations (IMA); Quidel (QDEL); Meridian Bioscience (VIVO); Gen-Probe (GPRO); Sequenom (SQNM); Genoptix (GXDX); Response Genetics (RGDX); Affymetrix (AFFX); Monogram Bioscience (MGRN); LabCorp (LH)


